Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001571049-17-003184
Filing Date
2017-04-05
Accepted
2017-04-05 11:16:49
Documents
9
Period of Report
2017-04-05

Document Format Files

Seq Description Document Type Size
1 FORM 6-K t1700966_6k.htm 6-K 15465
2 EXHIBIT 1.1 t1700966_ex1-1.htm EX-1.1 224700
3 EXHIBIT 5.1 t1700966_ex5-1.htm EX-5.1 32565
4 EXHIBIT 5.2 t1700966_ex5-2.htm EX-5.2 10392
5 EXHIBIT 99.1 t1700966_ex99-1.htm EX-99.1 10592
6 GRAPHIC t1700966_ex5-1p1.jpg GRAPHIC 12714
7 GRAPHIC t1700966_ex5-1p2.jpg GRAPHIC 8842
8 GRAPHIC t1700966_ex5-2p1.jpg GRAPHIC 4071
9 GRAPHIC t1700966_ex99-1logo.jpg GRAPHIC 12501
  Complete submission text file 0001571049-17-003184.txt   347943
Mailing Address 2 HAMA-AYAN STREET MODI-IN TECHNOLOGY PARK MODI-IN L3 7177871
Business Address 2 HAMA-AYAN STREET MODI-IN TECHNOLOGY PARK MODI-IN L3 7177871 972-2-548-9100
BioLineRx Ltd. (Filer) CIK: 0001498403 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-35223 | Film No.: 17741580
SIC: 2834 Pharmaceutical Preparations